Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.
New Approaches to Treating Peripheral Artery Disease Below-the-Knee (BTK) and Promising New BTK Data
Shared 1 year ago
314 views
Shared 1 year ago
266 views
Shared 3 years ago
276 views
Pantheris XL 95% Stenosis of the SFA Case study with Dr. Barry Tedder of St. Bernards Medical Center
Shared 3 years ago
367 views
Shared 3 years ago
469 views
Shared 3 years ago
50K views
Shared 5 years ago
935 views
Shared 5 years ago
1K views
Shared 5 years ago
720 views
Shared 5 years ago
334 views
Shared 5 years ago
1.4K views
Shared 5 years ago
625 views
Shared 6 years ago
8.9K views
Shared 6 years ago
689 views
Shared 6 years ago
1.9K views
Shared 6 years ago
1.6K views
Shared 6 years ago
4.9K views
Shared 6 years ago
486 views
Shared 6 years ago
7.9K views
Shared 6 years ago
1.1K views
Shared 7 years ago
24K views
Shared 7 years ago
2.3K views
Shared 9 years ago
412 views
Shared 9 years ago
1.6K views
Shared 9 years ago
270 views
Shared 10 years ago
506 views
Shared 10 years ago
1K views
Shared 10 years ago
1.2K views